<DOC>
	<DOCNO>NCT02834377</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness use personal preoperatively assessed cardiac output high-risk patient guide perioperative administration fluid vasoactive drug predefined postoperative complication .</brief_summary>
	<brief_title>Personalized Hemodynamic Therapy Patients Undergoing High-risk Surgery</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Patients ≥ 18 year undergo major abdominal procedure ( include general , urological , gynaecological , vascular ) expect duration surgery ≥ 90 min presume blood loss exceed 1,000 mL ( e.g. , intrabdominal vascular surgery ) ≥ 1 follow highrisk criterion : acute chronic renal impairment ( serum creatinine ≥ 1.3 mg/dL ) predefined risk factor cardiac respiratory complication Immunodeficiency due therapy ( e.g. , immunosuppressant , chemotherapy , radiation , longterm highdose steroid ) Immunodeficiency due specific disease ( e.g. , leukaemia , lymphoma , AIDS ) severe liver impairment ( biopsy proven liver cirrhosis plus 1 following : portal hypertension history upper gastrointestinal bleeding due portal hypertension previous episode hepatic insufficiency/hepatic encephalopathy/hepatic coma Age ≥ 80 year Age &lt; 18 year Pregnancy surgery palliative treatment emergency procedure refusal consent participation another randomize control trial failure meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiac Output</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Perioperative Care</keyword>
</DOC>